Yiyun Shi

Dr. Yiyun Shi


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2020 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
YSYiyun Shi
Yiyun Shi
APAakriti Pandita
Aakriti Pandita
AHAnna Hardesty
Anna Hardesty
MMMeghan McCarthy
Meghan McCarthy
JAJad Aridi
Jad Aridi
DFDimitrios Farmakiotis
Dimitrios Farmakiotis
Objective We aimed to externally validate the predictive performance of two recently developed COVID‐19‐specific prognostic tools, the COVID‐GRAM and CALL scores, and prior prognostic scores for community‐acquired pneumonia (CURB‐65), viral pneumonia (MuBLSTA) and H1N1 influenza pneumonia (Influenza risk score) in a contemporary US cohort. Methods We included 257 hospitalized patients with laboratory‐confirmed COVID‐19 pneumonia from three teaching hospitals in Rhode Island. We extracted data from within the first 24 hours of admission. Variables were excluded if values were missing in >20% of cases, otherwise missing values were imputed. 115 patients with complete data after imputation were used for primary analysis. Sensitivity analysis was done after exclusion of one variable (LDH) in the complete dataset (n=257). Primary and secondary outcomes were in‐hospital mortality and critical illness (mechanical ventilation or death), respectively. Results Only the areas under the receiver‐operating characteristic curves (RO‐AUC) of COVID‐GRAM (0.775, 95%CI 0.525‐0.915) for in‐hospital death, and CURB65 for in‐hospital death (RO‐AUC 0.842, 95%CI 0.674‐0.932) or critical illness (RO‐AUC=0.766, 95%CI 0.584‐0.884) were significantly better than random. Sensitivity analysis yielded similar trends. Calibration plots showed better agreement between estimated and observed probability of in‐hospital death for CURB65, compared to COVID‐GRAM. The negative predictive value (NPV) of CURB65≥2 was 97.2% for in‐hospital death and 88.1% for critical illness. Conclusions The COVID‐GRAM score demonstrated acceptable predictive performance for in‐hospital death. The CURB65 score had better prognostic utility for in‐hospital death and critical illness. The high NPV of CURB65 values ≥2, may be useful in triaging and allocation of resources.

1 May 2015 in Medicine
Verified
Journal Article
Open access
YSYiyun Shi
Yiyun Shi
ZLZhi-Ying Li
Zhi-Ying Li
MZMing-Hui Zhao
Ming-Hui Zhao
MCMin Chen
Min Chen
Patients with antineutrophil cytoplasmic autoantibody associated vasculitis (AAV) have a high prevalence of infection during immunosuppressive therapy, and the total lymphocyte count (TLC) has been demonstrated to be an independent predictor of infection. The current study investigated the value of the TLC and its subsets, particularly the CD4 count, for predicting infections of AAV in a single Chinese cohort.A total of 124 AAV patients were retrospectively recruited in our department from December 1997 to October 2013. Multivariate Cox models with the CD4 count or TLC measured at three typical time points, that is, at baseline, at the beginning of immunosuppressant dose reduction, and at the last visit before infection or censoring, or with the measurements included as time-varying covariates, were compared to select the most predictive time point for infection. A time-dependent area under the receiver operating characteristic curve (AUC(t)) for the TLC (AUC(t)TLC) and the CD4 count (AUC(t)CD4count) measured at the most predictive time point were calculated and compared.During an average follow-up of 11.5 (range 0.5-142) months, 55 of the 124 patients (44.3%) experienced a microbiologically confirmed infection. Independent predictors of overall infection were initial creatinine clearance (P = 0.02 and 0.04), pulmonary interstitial fibrosis (P = .04 and .05), pulmonary nodule or cavity (P = 0.002 and .002), CD4 count (P < 0.001) or TLC (P = 0.05) from the last visit. The comparison of Cox models fitted at different time points confirmed the last visit to be the most predictive one for overall infection. The predictive value of the CD4 count or TLC from the last visit measured by AUC showed that the AUC(t)CD4count (62.8-70.2%) was almost always higher than AUC(t)TLC (55.2-58.1%) during the first 2 years of immunosuppressive therapy (P = 0.01-0.2). In terms of different pathogens, both the CD4 count and TLC performed well for non-bacterial infection (AUC(t) 69.2-82.7%), and the difference between them was not significant (P > 0.1).The TLC and CD4 count were both independent risk factors of overall infection and non-bacterial infection in AAV patients. The CD4 count had a higher predictive value than the TLC for overall infections, particularly during the first 2 years of immunosuppressive therapy.

28 January 2022 in New Phytologist
Verified
Journal Article
Closed access
PDF file
YZYan Zhao
Yan Zhao
YSYiyun Shi
Yiyun Shi
GJGuanghuai Jiang
Guanghuai Jiang
YWYufeng Wu
Yufeng Wu
MMMiaomiao Ma
Miaomiao Ma
JZJian‐Min Zhou
Jian‐Min Zhou

1 May 2021 in Transplantation Proceedings
Verified
Journal Article
Closed access
AHAnna Hardesty
Anna Hardesty
APAakriti Pandita
Aakriti Pandita
KVKendra Vieira
Kendra Vieira
RRRalph Rogers
Ralph Rogers
BMBasma Merhi
Basma Merhi
DFDimitrios Farmakiotis
Dimitrios Farmakiotis

19 September 2022 in Hemato
Verified
Journal Article
Open access
PDF file
CWChen Wang
Chen Wang
YSYiyun Shi
Yiyun Shi
Extramedullary hematopoiesis is rarely seen in patients with myelodysplastic syndromes, and its clinical characterizations are not well-defined. Here, we systematically reviewed the published literature to summarize the clinical manifestations, treatments, and long-term outcomes of biopsy-proven extramedullary hematopoiesis in patients with myelodysplastic syndromes. We included 41 patients, and ring sideroblasts were the most common myelodysplastic subtype (30.6%). Extramedullary hematopoiesis was typically symptomatic on presentation due to local compression, frequently involving the liver or spleen (36.6%), or the paravertebral region (24.4%). Notably, ring sideroblasts were predominantly seen in patients with non-hepatosplenic involvement (38.5 vs. 6.7%, p = 0.034). Interventions, when required, usually included surgery (36.8%) or radiation (13.2%), which led to symptomatic improvement in 55.5% of patients. The median overall survival of the current cohort was 7 months. The current study confirms the rarity of extramedullary hematopoiesis as a complication of myelodysplastic syndromes; however, its outcomes in response to systemic modern therapies require further investigation.

10 September 2020 in Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics
Verified
Journal Article
Closed access
WSWeihua Sun
Weihua Sun
BWBingbing Wu
Bingbing Wu
MWMengyuan Wu
Mengyuan Wu
BYBin Yang
Bin Yang
PZPing Zhang
Ping Zhang
Wenhao ZhouWenhao Zhou
Wenhao Zhou
To carry out genetic and metabolite analysis for an infant with cerebral creatine deficiency syndrome type 2 (CCDS2). Clinical data of the child was collected. Whole-exome sequencing was carried out to identify potential variants by next generation sequencing. Candidate variants were confirmed by Sanger sequencing. Metabolites were determined by tandem mass spectrometry and magnetic resonance spectroscopy. Treatment was carried out following the diagnosis and genetic counseling for the affected family. Two novel heterozygous variants (c.289delC and c.392-1G>C) of the GAMT gene were identified in the proband, which were respectively inherited from her father and mother. In silico analysis suggested both variants to be pathogenic. Creatine (Cr) level of the child was very low, and cerebral guanidinoacetate (GAA) level was slightly increased. But both had recovered to normal in two weeks, and cerebral Cr level was significantly improved after two months. Intellectual and motor development of the child were significantly improved. The child was diagnosed with CCDS type 2, for which pathogenic variants of the GAMT gene may be accountable. Treatment has attained a satisfactory effect for the patient.